APA (7th ed.) Citation

KI, O. R., MM, R., ER, G., DK, P., N, A., P, A. Z. W., . . . YH, G. (2026). Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments. Open forum infectious diseases, 13(7), ofag447. https://doi.org/10.1093/ofid/ofag447

Chicago Style (17th ed.) Citation

KI, Oliveira Roster, et al. "Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments." Open Forum Infectious Diseases 13, no. 7 (2026): ofag447. https://doi.org/10.1093/ofid/ofag447.

MLA (9th ed.) Citation

KI, Oliveira Roster, et al. "Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments." Open Forum Infectious Diseases, vol. 13, no. 7, 2026, p. ofag447, https://doi.org/10.1093/ofid/ofag447.